184 studies found for:    "Visceral steatosis"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Terminated
Has Results
Fish Oil and Diet for the Treatment of Non-Alcoholic Steatohepatitis (NASH)
Conditions: Nonalcoholic Steatohepatitis (NASH);   Hepatic Steatosis
Interventions: Drug: Omega-3-acid ethyl esters (Lovaza);   Drug: Placebo
2 Active, not recruiting Phase IIb Study to Evaluate the Efficacy and Safety of GFT505 Versus Placebo in Patients With Non-Alcoholic Steatohepatitis (NASH)
Condition: Non-Alcoholic Steatohepatitis (NASH)
Interventions: Drug: GFT505 80mg;   Drug: GFT505 120mg;   Drug: Placebo
3 Completed Treatment of Nonalcoholic Steatohepatitis With Pioglitazone
Conditions: Fatty Liver;   Nonalcoholic Steatohepatitis
Intervention: Drug: Pioglitazone
4 Enrolling by invitation Colesevelam Versus Placebo in the Treatment of Nonalcoholic Steatohepatitis
Condition: Nonalcoholic Steatohepatitis
Intervention: Drug: Colesevelam Hcl
5 Unknown  Identification of Protective and Worsening Steatohepatitis (NASH) Factors
Conditions: Morbid Obesity;   Steatohepatitis;   Steatosis
Intervention: Procedure: hepatic biopsies
6 Completed Effects of Alanine in Patients With Nonalcoholic Steatohepatitis
Condition: Nonalcoholic Steatohepatitis
Intervention: Drug: L-alanine
7 Completed Effects of Coffee on Hepatic Steatosis Induced by a High Fructose Diet
Condition: Hepatic Steatosis
Interventions: Dietary Supplement: Ctl;   Dietary Supplement: High fructose diet; no coffee;   Dietary Supplement: fully torrefied, caffeine-free coffee;   Dietary Supplement: partially torrefied, caffeine-free coffee;   Dietary Supplement: Partially torrefied, caffeinated coffee
8 Active, not recruiting Hepatic De Novo Lipogenesis (DNL)in the Pathogenesis of Hepatic Steatosis in Obese Youth
Conditions: Hepatic Steatosis;   Fatty Liver
Intervention:
9 Completed Betaine in Patients With Nonalcoholic Steatohepatitis
Condition: Nonalcoholic Steatohepatitis
Interventions: Drug: Cystadane;   Drug: Identical Placebo
10 Recruiting Testosterone Replacement in Non-alcoholic Steatohepatitis (TEREPINS)
Conditions: Nonalcoholic Steatohepatitis;   Hypogonadism
Intervention: Drug: testosterone undecanoate
11 Completed
Has Results
Pentoxifylline in Patients With Nonalcoholic Steatohepatitis
Condition: Nonalcoholic Steatohepatitis
Interventions: Drug: pentoxifylline (PTX);   Drug: placebo
12 Completed Efficacy and Safety of Diamel in Patients With Nonalcoholic Steatohepatitis
Conditions: Nonalcoholic Steatohepatitis;   Insulin Resistance
Interventions: Dietary Supplement: Diamel;   Other: Placebo and lifestyle counseling
13 Completed Efficacy and Safety of Viusid in Patients With Nonalcoholic Steatohepatitis
Condition: Nonalcoholic Steatohepatitis
Interventions: Dietary Supplement: Viusid;   Other: Hypocaloric Diet with controlled exercise
14 Unknown  Influence of Hepatic Steatosis on the Therapeutic Effect of Entecavir in Chronic Hepatitis B Patients
Conditions: Chronic Hepatitis B;   Hepatic Steatosis
Interventions: Drug: entecavir;   Drug: essentiale + entecavir;   Drug: Vitamin E + entecavir
15 Completed The Effect of Protandim on Non-alcoholic Steatohepatitis
Condition: Non-Alcoholic Steatohepatitis
Interventions: Dietary Supplement: Protandim;   Dietary Supplement: Placebo
16 Unknown  Pentoxifylline/Nonalcoholic Steatohepatitis (NASH) Study: The Effect of Pentoxifylline on NASH
Conditions: Nonalcoholic Steatohepatitis;   Liver Diseases
Intervention: Drug: Pentoxifylline
17 Completed Intragastric Balloon for Treatment of Non Alcoholic Steatohepatitis (NASH)
Condition: Non Alcoholic Steatohepatitis
Interventions: Procedure: AHA diet plus exercise with BIB placement;   Procedure: AHA diet plus exercise with sham BIB placement
18 Recruiting Atorvastatin, L-Carnitine and Non-Alcoholic Steatohepatitis
Condition: Non-alcoholic Steatohepatitis
Interventions: Drug: Atorvastatin;   Drug: L-Carnitine;   Drug: Placebo
19 Recruiting Non Invasive Measurements of Fibrosis, Inflammation and Steatohepatitis in Morbidly Obese Patients
Conditions: Morbid Obesity;   Non Alcoholic Steatohepatitis
Intervention:
20 Completed The Impact of Deferasirox on Non-Alcoholic-Steatohepatitis
Conditions: Non-alcoholic Steatohepatitis;   Increased Iron Storage / Disturbed Distribution
Intervention: Drug: Exjade

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years